🚨 New BioFlux Newsletter! Critical ADC safety hold on Daiichi Sankyo & Merck. Landmark approvals: Omeros' Yartemlea for TA-TMA & Edwards' SAPIEN M3 for mitral valve. Dive into biotech & health tech trends! Read now: #BioFlux #Biotech #HealthTech #ADCs #Nextechie